Form 4: Pacific Biosciences CEO Christian Henry Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO Christian Henry sold 98,907 shares of Pacific Biosciences stock at an average price of $1.746 to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On September 16, 2024, Christian Henry, the President & CEO of Pacific Biosciences, sold 98,907 shares of common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted average price of $1.746, with individual prices ranging from $1.69 to $1.84 per share.
- Following the transaction, Henry directly owns 2,497,763 shares of Pacific Biosciences stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing reporting a stock sale by an executive to cover tax obligations. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.
Key Dates
| Date | Description |
|---|---|
| 09/16/2024 | Date of stock sale transaction |
| 09/17/2024 | Date of Form 4 signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.